Germany Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Published by: Global Markets Direct

Published: May. 16, 2008 - 314 Pages

Table of Contents

1 Table Of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Definitions

2.2.1 Drug delivery devices

3 Healthcare Sector Review

3.1 Healthcare Sector

3.2 Healthcare Expenditure

3.3 Healthcare Infrastructure

3.3.1 Healthcare Personnel Data

3.3.2 Healthcare Facilities Data

3.4 Healthcare Policy

4 Drug Delivery Devices in Germany

4.1 Drug Delivery Devices Overall Revenues (2000-2012)

4.2 Drug Delivery Devices Overall Volume (2000-2012)

4.3 Drug Delivery Devices Company Shares (2005-2006)

5 Inhalation Systems in Germany

5.1 Inhalation Systems Overall Revenues (2000-2012)

5.1.1 Metered Dose Inhaler Devices Overall Revenues (2000-2012)

5.1.2 Dry Powder Inhaler Devices Overall Revenues (2000-2012)

5.2 Inhalation Systems Overall Volume (2000-2012)

5.2.1 Metered Dose Inhaler Devices Overall Volume (2000-2012)

5.2.2 Dry Powder Inhaler Devices Overall Volume (2000-2012)

5.3 Inhalation Systems Average Price (2000-2012)

5.3.1 Metered Dose Inhaler Devices Average Price (2000-2012)

5.3.2 Dry Powder Inhaler Devices Average Price (2000-2012)

5.4 Inhalation Systems Distribution Share (2005-2006)

5.5 Inhalation Systems Company Share (2005-2006)

6 Infusion Systems in Germany

6.1 Infusion Systems Overall Revenues (2000-2012)

6.1.1 Infusion Disposable Sets Overall Revenue (2000-2012)

6.1.2 Syringe Pumps Overall Revenue (2000-2012)

6.1.3 Infusion Pumps Overall Revenues (2000-2012)

6.2 Infusion Systems Overall Volume (2000-2012)

6.2.1 Infusion Pumps Overall Volume (2000-2012)

6.2.2 Syringe Pumps Overall Volume (2000-2012)

6.2.3 Infusion Pumps Overall Volume (2000-2012)

6.3 Infusion Systems Average Price (2000-2012)

6.3.1 Infusion Pumps Average Price (2000-2012)

6.3.2 Syringe Pumps Average Price (2000-2012)

6.3.3 Infusion Disposable Sets Average Price (2000-2012)

6.4 Infusion Systems Distribution Share (2005-2006)

6.5 Infusion Systems Company Share (2005-2006)

7 Needle Free Injections in Germany

7.1 Needle Free Injections Overall Revenue (2000-2012)

7.2 Needle Free Injections Overall Volume (2000-2012)

7.3 Needle Free Injections Average Price (2000-2012)

7.4 Needle Free Injections Distribution Share (2005-2006)

7.5 Needle Free Injections Company Share (2005-2006)

8 AstraZeneca PLC Company Profile

8.1 Company Overview

8.2 Business Overview

8.2.1 Products

8.2.2 History

8.3 Locations And Subsidiaries

8.4 Other Locations & Subsidiaries

8.5 Financial Deals Landscape

8.5.1 AstraZeneca Completes $6,900 Million Private Placement

8.5.2 AstraZeneca Acquires MedImmune

8.5.3 AstraZeneca Acquires Biologics Manufacturing Facility From DSM Biologics

8.5.4 AstraZeneca Acquires Arrow Therapeutics

8.5.5 AstraZeneca Signs An Agreement With Palatin Technologies

8.5.6 AstraZeneca Signs An Agreement With Bristol-Myers Squibb

8.5.7 AstraZeneca Signs An Agreement With Cubist Pharmaceuticals

8.5.8 AstraZeneca Signs An Agreement With Par Pharmaceutical

8.5.9 Schering Signs An Agreement With AstraZeneca

8.5.10 AstraZeneca Signs An Agreement With Pozen

8.5.11 AstraZeneca Signs An Agreement With Abbott

8.5.12 AstraZeneca To Sell Its U.S Anaesthetic and Analgesic Product Portfolio To Abraxis BioScience

8.5.13 AstraZeneca Acquires KuDOS Pharmaceuticals

8.5.14 AstraZeneca Acquires A Stake In Protherics

8.5.15 AstraZeneca Signs An Agreement With Targacept

8.5.16 AstraZeneca Signs An Agreement With AtheroGenics

8.5.17 AstraZeneca UK Signs An Agreement With Protherics

8.5.18 AstraZeneca Signs An Agreement With Bayer Schering Pharma Aktiengesellschaft

8.5.19 AstraZeneca Signs An Agreement With Astex Therapeutics

8.5.20 AstraZeneca Signs An Agreement With Avanir Pharmaceuticals

8.5.21 AstraZeneca And Royal Cosun Sells Joint Venture Advanta To Syngenta

8.5.22 AstraZeneca Completes Private Placement Of $750 million

8.5.23 AstraZeneca Prices EUR750 Million Private Placement

8.5.24 AstraZeneca Prices Sterling Bond GBP350 Million And Euro750 Million Eurobond Private Placement

8.6 Recent Developments

8.6.1 Feb 22, 2008: AstraZeneca To Appeal Judgment In Alabama Medical Pricing Case

8.6.2 Feb 18, 2008: AstraZeneca Appoints Non-Executive Director

8.6.3 Dec 12, 2007: AstraZeneca Files Patent Infringement Actions in Response to Crestor ANDAs

8.6.4 Sep 28, 2007: AstraZeneca Appoints New CFO

8.6.5 Jul 25, 2007: AstraZeneca Appoints New Board Member

8.6.6 Jun 06, 2007: AstraZeneca CFO Resigns

8.6.7 Feb 22, 2007: AstraZeneca To Invest $120 Miilion For R&D In Macclesfield Site

8.6.8 Jan 30, 2007: Philips And Leading Healthcare Companies Join For Major Research And Development

8.6.9 Jan 22, 2007: AstraZeneca Makes $100 Million Research Investment In Boston

9 3M Company Profile

9.1 Company Overview

9.2 Business Overview

9.2.1 Consumer and Office

9.2.2 Display and Graphics

9.2.3 Electro and Communications

9.2.4 Health Care

9.2.5 Industrial and Transportation

9.2.6 Safety, Security and Protection Services

9.2.7 Products

9.3 Value Chain Analysis

9.3.1 Manufacturing

9.3.2 Product Development

9.3.3 Sales and Marketing

9.4 SWOT Analysis

9.4.1 3M Company Strengths

3M Company Weaknesses

3M Company Opportunities

3M Company Threats

9.5 Financial and Operational Review

9.6 Locations And Subsidiaries

9.7 Financial Deals Landscape

9.7.1 3M Canada Acquires Les Entreprises Solumed

9.7.2 3M Acquires Bondo

9.7.3 3M Acquires Lingualcare

9.7.4 3M Acquires Abzil Industria E Comercio

9.7.5 3M Acquires Neo Plast

9.7.6 3M Acquires Assets Of DMS Chile

9.7.7 3M Acquires Business Of Innovative Paper Technologies

9.7.8 3M Acquires Powell

9.7.9 Gen-Probe Signs An Agreement With 3M Company

9.7.10 3M Acquires Acolyte Biomedica

9.7.11 3M Acquires Sealed Air Corp.'S Interest In Polymask Corp.

9.7.12 3M Sells Its Pharmaceutical Business To Meda AB

9.7.13 3M Acquires SoftMed Systems

9.7.14 3M Sells its Pharmaceuticals Business to Graceway

9.7.15 Gen-Probe Signs An Agreement With 3M

9.7.16 3M Sells its Pharmaceutical Operations in the Asia Pacific Region to Ironbridge Capital and Archer Capital

9.7.17 3M Acquires Biotrace International

9.7.18 Ekahau Secures $16 Million In Additional Funding

9.7.19 3M Acquires Brontes Technologies

9.7.20 3M acquires Nylonge Corp

9.7.21 3M Signs An Agreement With ClozeX Medical

9.7.22 3M Acquires OMNII Oral Pharmaceuticals

9.7.23 3M Sells Pharmaceutical Operations In The United States To Graceway

9.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB

9.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer Capital

9.7.26 3M Acquires Accuspray Application Technologies Inc.

9.7.27 3M to acquire Rochford Thompson Equipment

9.7.28 3M To Acquire Aearo Technologies From Permira

9.7.29 Permira To Sell Aearo Technologies To 3M

9.8 Recent Developments

9.8.1 Mar 31, 2008: HighJump Software Introduces Survey Management Solution for Direct Store Delivery Businesses

9.8.2 Mar 24, 2008: Brazil's Companhia de Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State

9.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in Asia

9.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business In North Asia

9.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th Straight Year

9.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend

9.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery

9.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend

9.8.9 May 08, 2007: 3M Declares Quarterly Dividend

9.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests

10 GlaxoSmithKline plc Company Profile

10.1 Company Overview

10.2 Business Overview

10.2.1 Products

10.2.2 History

10.3 Locations And Subsidiaries

10.4 Other Locations & Subsidiaries

10.5 Financial Deals Landscape

10.5.1 GlaxoSmithKline Acquires CNS

10.5.2 Bayer HealthCare Acquires Pritor Business From GlaxoSmithKline

10.5.3 CNS To Merge With GlaxoSmithKline

10.6 Recent Developments

10.6.1 Mar 19, 2008: GSK charitable support valued at GBP282 million in 2007

10.6.2 Feb 07, 2008: Full-year results announcement 2007

10.6.3 Dec 19, 2007: GlaxoSmithKline And Santaris Enter Global R&D Alliance

10.6.4 Dec 10, 2007: GlaxoSmithKline And OncoMed Form Strategic Alliance To Develop Cancer Stem Cell Antibody Therapeutics

10.6.5 Dec 07, 2007: GlaxoSmithKline Announces Board And Management Changes

11 Baxter International Company Profile

11.1 Company Overview

11.2 Business Overview

11.2.1 BioScience

11.2.2 Medication Delivery

11.2.3 Renal

11.2.4 Products

11.2.5 History

11.3 Value Chain Analysis

11.3.1 Manufacturing

11.3.2 Product Development

11.3.3 Sales and Marketing

11.4 SWOT Analysis

11.4.1 Baxter International Inc. Strengths

11.4.2 Baxter International Inc. Weaknesses

11.4.3 Baxter International Inc. Opportunities

11.4.4 Baxter International Inc. Threats

11.5 Financial and Operational Review

11.6 Locations And Subsidiaries

11.7 Other Locations & Subsidiaries

11.8 Financial Deals Landscape

11.8.1 Baiyunshan And Baxter Form A Joint Venture In China

11.8.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration

11.8.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital

11.8.4 B. Braun Acquires Renal Therapy Business Of Baxter

11.8.5 Innovata signs a license agreement with Baxter International

11.8.6 Kuros Biosurgery Signs An Agreement With Baxter International

11.8.7 Gambro Signs An Agreement With Baxter

11.8.8 Baxter Healthcare And Gambro Enter Into An Agreement

11.8.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System

11.8.10 Baxter International And Kaketsuken Enter Into Agreement

11.8.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful

11.9 Recent Developments

11.9.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007

11.9.2 Dec 18, 2007: Baxter Elects CFO

11.9.3 Nov 13, 2007: Baxter Declares Quarterly Dividend

11.9.4 Aug 01, 2007: Baxter Elects New Board Director

11.9.5 Jul 31, 2007: Baxter Announces Quarterly Dividend

11.9.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization

11.9.7 Feb 13, 2007: Baxter Announces Quarterly Dividend

11.9.8 Nov 28, 2006: Baxter Announces Annual Dividend

11.9.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America

11.10 Baxter International Inc. Pipeline Products

11.10.1 Next-Generation Home Hemodialysis Machine

12 Novartis AG Company Profile

12.1 Company Overview

12.2 Business Overview

12.2.1 Major Products and Services

12.3 Locations And Subsidiaries

12.4 Other Locations & Subsidiaries

12.5 Financial Deals Landscape

12.5.1 Bayer Schering Pharma Acquires U.S. Biologics Manufacturing Facility From Novartis

12.5.2 Novartis To Acquire Majority Stake In Alcon From Nestle

12.5.3 Novartis to sell Medical Nutrition business unit to Nestlé

12.5.4 Nestlé to Acquire Novartis Medical Nutrition

12.5.5 Novartis to sell its division Gerber Products Company to Nestle

13 Regulation System

13.1 Regulation System

13.2 Medical Equipment Approval Process

13.2.1 Classification of Medical Devices

13.3 Conformity Assessment Process

13.3.1 Class I devices

13.3.2 Class IIa devices

13.3.3 Class IIb devices

13.3.4 Class III devices

13.4 Post Market Surveillance

14 Pricing and Reimbursement

14.1 SHI

14.1.1 Private Health Insurance

14.1.2 Diagnosis Related Groups (DRG)

15 Distribution Structure

16 APPENDIX

16.1 Global Markets Direct Research Methodology

16.2 Coverage

16.3 Secondary Research

16.4 Primary Research

16.5 Models

16.6 Forecasts

16.7 Expert Panels

16.8 Currency Conversion

16.9 Contact Us

16.10 Disclaimer

1.1 List of Tables

Table 1: Healthcare Personnel by Region in Germany, 2004

Table 2: Doctors by Specialty in Germany, 2000-2004

Table 3: Hospitals by Region in Germany, 2004

Table 4: Hospital Beds by Region in Germany, 2004

Table 5: Rehabilitation Centers by Region in Germany, 2004

Table 6: Rehabilitation Center Beds by Region in Germany, 2004

Table 7: Discharges by Diagnosis in Germany, 2004

Table 8: Drug Delivery Devices, Germany, Overall Revenues ($ mn), 2000-2012

Table 9: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Table 10: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Table 11: Drug Delivery Devices, Germany, Category Revenues ($ mn), 2000-2012

Table 12: Drug Delivery Devices, Germany, Category Revenues ($ mn), Historic, 2000-2007

Table 13: Drug Delivery Devices, Germany, Category Revenues ($ mn), Forecast, 2007-2012

Table 14: Drug Delivery Devices, Germany, Category Volume (Units), 2000-2012

Table 15: Drug Delivery Devices, Germany, Category Volume (Units), Historic, 2000-2007

Table 16: Drug Delivery Devices, Germany, Category Volume (Units), Forecast, 2007-2012

Table 17: Drug Delivery Devices, Germany, Company Share by Revenue ($ mn), 2005-2006

Table 18: Inhalation Systems, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Table 19: Inhalation Systems, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Table 20: Inhalation Systems, Germany, Revenue by Segment ($ mn), Historic, 2000-2007

Table 21: Inhalation Systems, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 22: Metered Dose Inhaler Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Table 23: Metered Dose Inhaler Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Table 24: Dry Powder Inhaler Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Table 25: Dry Powder Inhaler Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Table 26: Inhalation Systems, Germany, Overall Volume (Units), Historic, 2000-2007

Table 27: Inhalation Systems, Germany, Overall Volume (Units), Forecast, 2007-2012

Table 28: Metered Dose Inhaler Devices, Germany, Overall Volume (Units), Historic, 2000-2007

Table 29: Metered Dose Inhaler Devices, Germany, Overall Volume (Units), Forecast, 2007-2012

Table 30: Dry Powder Inhaler Devices, Germany, Overall Volume (Units), Historic, 2000-2007

Table 31: Dry Powder Inhaler Devices, Germany, Overall Volume (Units), Forecast, 2007-2012

Table 32: Metered Dose Inhaler Devices, Germany, Average Price ($), Historic, 2000-2007

Table 33: Metered Dose Inhaler Devices, Germany, Average Price ($), Forecast, 2007-2012

Table 34: Dry Powder Inhaler Devices, Germany, Average Price ($), Historic, 2000-2007

Table 35: Dry Powder Inhaler Devices, Germany, Average Price ($), Forecast, 2007-2012

Table 36: Inhalation Systems, Germany, Distribution Share by Revenue ($ mn), 2005-2006

Table 37: Inhalation Systems, Germany, Company Share by Revenue ($ mn), 2005-2006

Table 38: Infusion Systems, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Table 39: Infusion Systems, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Table 40: Infusion Systems, Germany, Revenue by Segment ($ mn), Historic, 2000-2007

Table 41: Infusion Systems, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 42: Infusion Disposable Sets, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Table 43: Infusion Disposable Sets, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Table 44: Syringe Pumps, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Table 45: Syringe Pumps, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Table 46: Infusion Pumps, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Table 47: Infusion Pumps, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Table 48: Infusion Systems, Germany, Overall Volume (Units), Historic, 2000-2007

Table 49: Infusion Systems, Germany, Overall Volume (Units), Forecast, 2007-2012

Table 50: Infusion Disposable Sets, Germany, Overall Volume (Units), Historic, 2000-2007

Table 51: Infusion Disposable Sets, Germany, Overall Volume (Units), Forecast, 2007-2012

Table 52: Syringe Pumps, Germany, Overall Volume (Units), Historic, 2000-2007

Table 53: Syringe Pumps, Germany, Overall Volume (Units), Forecast, 2007-2012

Table 54: Infusion Pumps, Germany, Overall Volume (Units), Historic, 2000-2007

Table 55: Infusion Pumps, Germany, Overall Volume (Units), Forecast, 2007-2012

Table 56: Infusion Pumps, Germany, Average Price ($), Historic, 2000-2007

Table 57: Infusion Pumps, Germany, Average Price ($), Forecast, 2007-2012

Table 58: Syringe Pumps, Germany, Average Price ($), Historic, 2000-2007

Table 59: Syringe Pumps, Germany, Average Price ($), Forecast, 2007-2012

Table 60: Infusion Disposable Sets, Germany, Average Price ($), Historic, 2000-2007

Table 61: Infusion Disposable Sets, Germany, Average Price ($), Forecast, 2007-2012

Table 62: Infusion Systems, Germany, Distribution Share by Revenue ($ mn), 2005-2006

Table 63: Infusion Systems, Germany, Company Share by Revenue ($ mn), 2005-2006

Table 64: Needle Free Injections, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Table 65: Needle Free Injections, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Table 66: Needle Free Injections, Germany, Overall Volume (Units), Historic, 2000-2007

Table 67: Needle Free Injections, Germany, Overall Volume (Units), Forecast, 2007-2012

Table 68: Needle Free Injections, Germany, Average Price ($), Historic, 2000-2007

Table 69: Needle Free Injections, Germany, Average Price ($), Forecast, 2007-2012

Table 70: Needle Free Injections, Germany, Distribution Share by Revenue ($ mn), 2005-2006

Table 71: Needle Free Injections, Germany, Company Share by Revenue ($ mn), 2005-2006

Table 72: AstraZeneca PLC, Subsidiaries

Table 73: 3M Company, SWOT Analysis, 2006

Table 74: 3M Company, Financial Statements, USD Million, 2002-2006

Table 75: 3M Company, Financial and Operational Overview, USD Million, 2002-2006

Table 76: 3M Company, Subsidiaries

Table 77: GlaxoSmithKline plc, Subsidiaries

Table 78: Baxter International Inc., SWOT Analysis, 2006

Table 79: Baxter International Inc., Financial Statements, USD Million, 2002-2006

Table 80: Baxter International Inc., Financial Ratios, USD Million, 2002-2006

Table 81: Baxter International Inc., Other Locations

Table 82: Baxter International Inc., Subsidiaries

Table 83: Novartis Medical Nutrition, Other Locations

Table 84: Currency Conversion from USD to Local Currency at 2007 Constant Rate

1.2 List of Figures

Figure 1: Healthcare Structure in Germany, 2000 - 2006

Figure 2: Healthcare Expenditure Sources in Germany, 2003

Figure 3: Healthcare Financing Framework in Germany, 2007

Figure 4: Drug Delivery Devices, Germany, Overall Revenues ($ mn), 2000-2012

Figure 5: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Figure 6: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 7: Drug Delivery Devices, Germany, Category Revenues ($ mn), 2000-2012

Figure 8: Drug Delivery Devices, Germany, Category Revenues ($ mn), Historic, 2000-2007

Figure 9: Drug Delivery Devices, Germany, Category Revenues ($ mn), Forecast, 2007-2012

Figure 10: Drug Delivery Devices, Germany, Category Volume (Units), 2000-2012

Figure 11: Drug Delivery Devices, Germany, Category Volume (Units), Historic, 2000-2007

Figure 12: Drug Delivery Devices, Germany, Category Volume (Units), Forecast, 2007-2012

Figure 13: Drug Delivery Devices, Germany, Company Share (%), 2006

Figure 14: Inhalation Systems, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Figure 15: Inhalation Systems, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 16: Inhalation Systems, Germany, Revenue by Segment ($ mn), Historic, 2000-2007

Figure 17: Inhalation Systems, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012

Figure 18: Metered Dose Inhaler Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Figure 19: Metered Dose Inhaler Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 20: Dry Powder Inhaler Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Figure 21: Dry Powder Inhaler Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 22: Inhalation Systems, Germany, Overall Volume (Units), Historic, 2000-2007

Figure 23: Inhalation Systems, Germany, Overall Volume (Units), Forecast, 2007-2012

Figure 24: Metered Dose Inhaler Devices, Germany, Overall Volume (Units), Historic, 2000-2007

Figure 25: Metered Dose Inhaler Devices, Germany, Overall Volume (Units), Forecast, 2007-2012

Figure 26: Dry Powder Inhaler Devices, Germany, Overall Volume (Units), Historic, 2000-2007

Figure 27: Dry Powder Inhaler Devices, Germany, Overall Volume (Units), Forecast, 2007-2012

Figure 28: Metered Dose Inhaler Devices, Germany, Average Price ($), Historic, 2000-2007

Figure 29: Metered Dose Inhaler Devices, Germany, Average Price ($), Forecast, 2007-2012

Figure 30: Dry Powder Inhaler Devices, Germany, Average Price ($), Historic, 2000-2007

Figure 31: Dry Powder Inhaler Devices, Germany, Average Price ($), Forecast, 2007-2012

Figure 32: Inhalation Systems, Germany, Distribution Share (%), 2006

Figure 33: Inhalation Systems, Germany, Company Share (%), 2006

Figure 34: Infusion Systems, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Figure 35: Infusion Systems, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 36: Infusion Systems, Germany, Revenue by Segment ($ mn), Historic, 2000-2007

Figure 37: Infusion Systems, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012

Figure 38: Infusion Disposable Sets, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Figure 39: Infusion Disposable Sets, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 40: Syringe Pumps, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Figure 41: Syringe Pumps, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 42: Infusion Pumps, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Figure 43: Infusion Pumps, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 44: Infusion Disposable Sets, Germany, Overall Volume (Units), Historic, 2000-2007

Figure 45: Infusion Disposable Sets, Germany, Overall Volume (Units), Forecast, 2007-2012

Figure 46: Syringe Pumps, Germany, Overall Volume (Units), Historic, 2000-2007

Figure 47: Syringe Pumps, Germany, Overall Volume (Units), Forecast, 2007-2012

Figure 48: Infusion Pumps, Germany, Overall Volume (Units), Historic, 2000-2007

Figure 49: Infusion Pumps, Germany, Overall Volume (Units), Forecast, 2007-2012

Figure 50: Infusion Pumps, Germany, Average Price ($), Historic, 2000-2007

Figure 51: Infusion Pumps, Germany, Average Price ($), Forecast, 2007-2012

Figure 52: Syringe Pumps, Germany, Average Price ($), Historic, 2000-2007

Figure 53: Syringe Pumps, Germany, Average Price ($), Forecast, 2007-2012

Figure 54: Infusion Disposable Sets, Germany, Average Price ($), Historic, 2000-2007

Figure 55: Infusion Disposable Sets, Germany, Average Price ($), Forecast, 2007-2012

Figure 56: Infusion Systems, Germany, Distribution Share (%), 2006

Figure 57: Infusion Systems, Germany, Company Share (%), 2006

Figure 58: Needle Free Injections, Germany, Overall Revenues ($ mn), Historic, 2000-2007

Figure 59: Needle Free Injections, Germany, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 60: Needle Free Injections, Germany, Overall Volume (Units), Historic, 2000-2007

Figure 61: Needle Free Injections, Germany, Overall Volume (Units), Forecast, 2007-2012

Figure 62: Needle Free Injections, Germany, Average Price ($), Historic, 2000-2007

Figure 63: Needle Free Injections, Germany, Average Price ($), Forecast, 2007-2012

Figure 64: Needle Free Injections, Germany, Distribution Share (%), 2006

Figure 65: 3M Company, Value Chain Analysis

Figure 66: Baxter International Inc., Value Chain Analysis

Figure 67: Flowchart for Classification of Non-invasive Devices in Germany, 2007

Figure 68: Flowchart for Classification of Invasive Devices in Germany, 2007

Figure 69: Flowchart for Classification of Invasive Devices in Germany, 2007

Figure 70: Classification of Invasive Devices in Germany, 2007

Figure 71: Classification of Invasive Devices in Germany, 2007

Figure 72: Flowchart for Classification of Active Devices in Germany, 2007

Figure 73: Flowchart for Classification of Active Devices in Germany, 2007

Figure 74: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Germany, 2007

Figure 75: Conformity Assessment of Class-I Medical Devices in Germany, 2007

Figure 76: Conformity Assessment of Class-IIa Medical Devices in Germany, 2007

Figure 77: Conformity Assessment of Class-IIb Medical Devices in Germany, 2007

Figure 78: Conformity Assessment of Class-III Medical Devices in Germany, 2007

Figure 79: Global Markets Direct Methodology

Abstract

• The report provides drug delivery devices information broken down into detailed categories and segments in Germany.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the drug delivery devices market in Germany.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.